Laboratory Corporation of... (LH)
Laboratory of America Statistics
Share Statistics
Laboratory of America has 83.67M shares outstanding. The number of shares has increased by -0.7% in one year.
| Shares Outstanding | 83.67M |
| Shares Change (YoY) | -0.7% |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | 93.06% |
| Shares Floating | 83.34M |
| Failed to Deliver (FTD) Shares | 9 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.89M, so 2.26% of the outstanding shares have been sold short.
| Short Interest | 1.89M |
| Short % of Shares Out | 2.26% |
| Short % of Float | 3.01% |
| Short Ratio (days to cover) | 3.11 |
Valuation Ratios
The PE ratio is 25.7 and the forward PE ratio is 12.31. Laboratory of America's PEG ratio is 0.3.
| PE Ratio | 25.7 |
| Forward PE | 12.31 |
| PS Ratio | 1.47 |
| Forward PS | 1.5 |
| PB Ratio | 2.38 |
| P/FCF Ratio | 17.49 |
| PEG Ratio | 0.3 |
Enterprise Valuation
Laboratory of America has an Enterprise Value (EV) of 24.93B.
| EV / Sales | 1.92 |
| EV / EBITDA | 13.76 |
| EV / EBIT | 15.72 |
| EV / FCF | 22.74 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.9.
| Current Ratio | 1.44 |
| Quick Ratio | 1.3 |
| Debt / Equity | 0.9 |
| Debt / EBITDA | 4.02 |
| Debt / FCF | 6.64 |
| Interest Coverage | 5.31 |
Financial Efficiency
Return on Equity is 9.26% and Return on Invested Capital is 5.3%.
| Return on Equity | 9.26% |
| Return on Assets | 4.06% |
| Return on Invested Capital | 5.3% |
| Revenue Per Employee | $213.61K |
| Profits Per Employee | $12.25K |
| Employee Count | 60,900 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 19.28 |
Taxes
| Income Tax | 212.4M |
| Effective Tax Rate | 22.14% |
Stock Price Statistics
The stock price has increased by 8.9% in the last 52 weeks. The beta is 0.97, so Laboratory of America's price volatility has been higher than the market average.
| Beta | 0.97 |
| 52-Week Price Change | 8.9% |
| 50-Day Moving Average | 239.04 |
| 200-Day Moving Average | 230.18 |
| Relative Strength Index (RSI) | 37.68 |
| Average Volume (20 Days) | 709.2K |
Income Statement
In the last 12 months, Laboratory of America had revenue of 13.01B and earned 746M in profits. Earnings per share was 8.92.
| Revenue | 13.01B |
| Gross Profit | 3.5B |
| Operating Income | 1.11B |
| Net Income | 746M |
| EBITDA | 1.81B |
| EBIT | 1.17B |
| Earnings Per Share (EPS) | 8.92 |
Balance Sheet
The company has 1.52B in cash and 7.27B in debt, giving a net cash position of -5.75B.
| Cash & Cash Equivalents | 1.52B |
| Total Debt | 7.27B |
| Net Cash | -5.75B |
| Retained Earnings | 8.3B |
| Total Assets | 18.38B |
| Working Capital | 1.48B |
Cash Flow
In the last 12 months, operating cash flow was 1.59B and capital expenditures -489.9M, giving a free cash flow of 1.1B.
| Operating Cash Flow | 1.59B |
| Capital Expenditures | -489.9M |
| Free Cash Flow | 1.1B |
| FCF Per Share | 13.11 |
Margins
Gross margin is 26.92%, with operating and profit margins of 8.5% and 5.73%.
| Gross Margin | 26.92% |
| Operating Margin | 8.5% |
| Pretax Margin | 7.38% |
| Profit Margin | 5.73% |
| EBITDA Margin | 13.92% |
| EBIT Margin | 8.5% |
| FCF Margin | 8.42% |
Dividends & Yields
LH pays an annual dividend of $2.88, which amounts to a dividend yield of 1.31%.
| Dividend Per Share | $2.88 |
| Dividend Yield | 1.31% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 32.58% |
| Earnings Yield | 3.89% |
| FCF Yield | 5.72% |
Analyst Forecast
The average price target for LH is $267.5, which is 23.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $267.5 |
| Price Target Difference | 23.2% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
Stock Splits
The last stock split was on Jul 3, 2023. It was a forward split with a ratio of 291:250.
| Last Split Date | Jul 3, 2023 |
| Split Type | forward |
| Split Ratio | 291:250 |
Scores
| Altman Z-Score | 2.75 |
| Piotroski F-Score | 9 |